During a recent planning call for a patient disease management program the discussion turned to metrics. Key to any program design is agreement on what outcomes will be measured and what will be deemed success. It makes no sense to launch a program without developing goals about levels of engagement, target clinical results, and ultimately financial payback.
So far so good, right?
Until we moved beyond vague generalities about impact and tried to identify the actual sources of patient data that would validate the program.
- “We only get about 10% of the patient lab results we request.”
- “We attempt to get physicians to attest to patient check-ups in writing, and you know how that goes.”
- “Legal has deep concerns about merging patient data sources.”
So how then do these brands continue to sell expensive patient programs without validated outcomes?